-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Vice Governor Hu Qisheng Conducts Research Visit to Shijiazhuang Sihua Pharmaceutical Group
Category:
发布时间：2021-09-30
【概要描述】
On September 28, Hu Qisheng, Vice Governor of Hebei Province, visited Shijiazhuang No. 4 Pharmaceutical Group and other pharmaceutical enterprises to conduct a field inspection on the innovative development of the pharmaceutical industry and the implementation of measures to address issues raised by these companies.
On September 28, Hu Qisheng, Vice Governor of Hebei Province, visited Shijiazhuang Sihua Pharmaceutical Group and other pharmaceutical enterprises to conduct an inspection on the innovative development of the pharmaceutical industry and the implementation of measures to address issues raised by these companies. He emphasized the need to earnestly carry out the directives issued by the Provincial Party Committee and the Provincial Government, accelerate the establishment of a modernized pharmaceutical industry system, cultivate new competitive advantages, promote industrial transformation and upgrading, and foster high-quality development of the province’s pharmaceutical sector.
Hu Qisheng and his delegation visited the Pharmaceutical Research Institute of Shijiazhuang No. 4 Pharmaceutical Group, where they gained a detailed understanding of the company’s innovation and R&D efforts, industrial planning, production and operations, and talent development. They also held in-depth discussions with key corporate leaders, including Qu Jiguang, Chairman of the Board of Shijiazhuang No. 4 Pharmaceutical Group, and commended the company’s commitment to innovation-driven development, its sense of responsibility and effective practices in striving to grow stronger, larger, and better. Hu warmly encouraged the company to seize opportunities, continue its hard work, highlight its distinctive strengths, and make greater contributions and assume greater responsibilities in advancing the innovative, green, and high-quality development of Hebei’s pharmaceutical industry.
Hu Qisheng pointed out that the pharmaceutical industry is vital to public health and well-being as well as to the cultivation of new growth drivers, and it boasts broad market prospects. Enterprises must steadfastly regard innovation as the primary driver of high-quality development, strive for technological self-reliance and strength, increase R&D investment, stimulate the enthusiasm of scientific and technical personnel, and accelerate the industrialization of research findings, thereby securing a bright future through innovation.
Hu Qisheng urged all levels and relevant departments to earnestly implement the “Several Measures for Supporting the Development of the Pharmaceutical Industry,” focusing on the cutting edge of the industry and emerging trends. They should adopt a comprehensive approach that emphasizes innovation, talent development, environmental protection, and market access, guiding enterprises to raise product standards, build high-end brands, actively attract supporting firms in the pharmaceutical packaging materials value chain, and accelerate the enhancement of the overall competitiveness of the pharmaceutical industry. Furthermore, they should carry out the “Three Priorities, Four Innovations, Five Optimizations” campaign in depth, ensure the effective fulfillment of assigned liaison responsibilities, optimize the business environment, gain a thorough understanding of enterprises’ concerns, aspirations, and expectations, enhance the targeted nature, effectiveness, and substantive value of industrial policies, and make every possible effort to help enterprises resolve their difficulties, thereby speeding up the drive for high-quality development of the pharmaceutical industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091